Pathogen Virulence Factors – Types, Mechanisms and Examples

Pathogenicity is the capacity of a microorganism to cause disease in a host. Virulence refers to the intensity or degree of pathogenicity. The virulence varies among different microorganisms and also among strains of same species.

Virulence factors are the structures, substances or properties which help a pathogen to cause infection. These factors help the microorganism to attach with host cells, enter into tissues and escape from host defence. It also causes damage to the host cells. Adhesins, invasive enzymes, toxins, capsule and secretion systems are some of them.

Attachment is the initial process of infection. It is carried out by surface structures called adhesins. Bacterial pili, fimbriae and viral spike proteins bind with the specific receptors present on host cells. After this binding, the pathogen remains attached and starts colonization.

Some bacterial pathogens produce different enzymes for tissue invasion. Hyaluronidase and collagenase break the substances present between the host cells. During this process, connective tissues and extracellular matrix are degraded. The pathogen now spreads into deeper tissues and may enter the bloodstream.

Production of toxins is referred to as toxigenicity. The two major bacterial toxins are endotoxins and exotoxins. Endotoxin is a heat-stable lipopolysaccharide (LPS) present in outer membrane of Gram-negative bacteria. The lipid A part is toxic, which causes inflammation, fever and shock after its release.

Exotoxins are toxic proteins secreted by Gram-positive and Gram-negative bacteria. These toxins act on specific cells or cellular processes. A-B toxins enter the host cells and affect different internal activities such as protein synthesis. Membrane-disrupting toxins damage the cell membrane, while superantigens cause excess and non-specific immune response.

The pathogen also needs to survive against host immune system. A polysaccharide capsule covers the surface antigen and prevents engulfment by phagocytic cells. Some pathogens produce proteases for degradation of antibodies. Coagulase forms a protective clot around the pathogen.

Antigenic variation is the continuous change of surface antigens by the pathogen. Due to this change, the antibodies already formed cannot recognize it properly. Some bacteria also use Type III secretion system and Type VI secretion system. These systems inject virulence proteins directly into the host cells, which change the normal cellular activities and support the survival of pathogen.

What are Pathogen Virulence Factors?

Pathogen virulence factors are specific structures, substances or characters which help a microorganism to invade the host and produce disease. These factors are present in bacteria, viruses and fungi, and help in attachment, tissue invasion, escaping from host immune defence and damage of host cells. Pili, viral spike proteins, capsules, tissue-degrading enzymes and toxins are some of them. The type and combination of these factors determine the severity of disease produced by the pathogen.

Characteristics of Virulence Factors

The following are the major characteristics of virulence factors–

• Genetic control – Virulence factors are encoded by genes present in chromosomal DNA, plasmids, transposons or bacteriophages. Some of these genes are present on mobile genetic elements and can be transferred from one microorganism to another by horizontal gene transfer.
• Adhesion – Virulence factors help the pathogen to attach with host cells and mucosal surfaces. Pili, fimbriae and surface adhesin proteins are used for this attachment. It prevents the removal of pathogen from the host tissue.
• Tissue invasion – Some virulence factors are enzymes which break the host tissues. Collagenase, hyaluronidase and nucleases degrade connective tissues, cell membranes and extracellular matrix, which helps the pathogen to spread into deeper region.
• Immune evasion – These factors help the pathogen to escape from host immune system. A thick capsule prevents phagocytosis, while some proteases degrade host antibodies. Antigenic variation also changes the surface proteins and prevents proper recognition by immune cells.
• Toxin production – Production of toxins by the pathogen is referred to as toxigenicity. Exotoxins are heat-labile proteins secreted by microorganisms, whereas endotoxins are heat-stable lipopolysaccharides present in Gram-negative bacterial membrane. These toxins cause cell damage, inflammation and shock.
• Nutrient acquisition – Virulence factors also help in obtaining nutrients from the host. Siderophores bind with iron and remove it from host iron-binding proteins. The obtained iron is then used for microbial growth and multiplication.
• Specialized secretion system – Some bacteria possess different secretion systems for transport of virulence proteins. Type I to Type IX secretion systems may release these proteins outside the bacterial cell or inject them directly into host cells. This changes the normal activity of host cell.
• Environmental regulation – The production of virulence factors is controlled by different environmental conditions. Temperature, pH, nutrient level and host immune pressure can increase or decrease their expression. Thus, the factors are not produced in same amount during all conditions.
• Specificity – Some virulence factors are common in both pathogenic and non-pathogenic strains and mainly help in survival or attachment. Other factors are pathogen-specific and are found mainly in disease-causing strains. These factors are generally involved in severe tissue damage and toxemia.

Pathogenicity vs Virulence

Types of Pathogen Virulence Factors

The following are the major types of pathogen virulence factors–

1. Adhesion factors– These factors help the pathogen to attach with the host cells and tissue surfaces. Adhesins, pili, fimbriae and viral attachment proteins are included in this type. The attachment prevents removal of pathogen by mucus, urine or other body fluids.
2. Capsule and glycocalyx– Capsule is an outer covering present around some bacterial cells. It masks the surface antigens and prevents phagocytosis. The glycocalyx also helps in attachment and protection of pathogen from antibodies and complement proteins.
3. Biofilm-forming factors– Biofilm is a group of microorganisms attached to a living or non-living surface and covered by an extracellular polymeric substance (EPS). This matrix protects the organisms from immune cells and reduces penetration of antimicrobial agents. It is commonly formed on catheters, implants and other medical devices.
4. Invasins– Invasins are proteins which help the pathogen to enter into host cells and cross epithelial barriers. Some of them cause membrane ruffling and uptake of bacterial cells by endocytosis. Salmonella, Shigella and Yersinia use different invasins during infection.
5. Extracellular enzymes or exoenzymes– These enzymes break the tissue barriers and help in spread of pathogen. Hyaluronidase breaks hyaluronic acid, while collagenase degrades collagen. Coagulase, kinases, DNase, proteases and lipases are other important exoenzymes.
6. Toxins– Toxins are harmful substances which damage host cells and tissues. Exotoxins are mainly protein toxins secreted by living bacterial cells, whereas endotoxin is the lipid A part of lipopolysaccharide (LPS) present in Gram-negative bacteria. A-B toxins, membrane-disrupting toxins and superantigens are major forms of exotoxins.
7. Immune-evasion factors– These factors help the pathogen to escape from the host immune system. Capsule prevents phagocytosis, antigenic variation changes the surface antigens and proteases degrade antibodies. Some pathogens also survive inside phagocytic cells or prevent fusion of phagosome with lysosome.
8. Iron and nutrient acquisition factors– Pathogens require iron and other nutrients for growth. Siderophores bind iron with high affinity and remove it from host iron-binding proteins. Some pathogens also possess receptors for transferrin, lactoferrin and haemoglobin.
9. Motility and chemotaxis factors– Flagella provide movement to bacterial cells and help in colonization. Chemotaxis allows the pathogen to move towards nutrients and favourable host regions. It also helps in penetration of mucus and spread through host tissues.
10. Secretion systems– Secretion systems are complex protein structures which transport virulence molecules outside the bacterial cell or directly into host cells. Type I to Type XI secretion systems have been described in bacteria. The injected proteins alter host cell activity, damage tissues or suppress immune responses.
11. Stress-resistance factors– These factors protect the pathogen from unfavourable conditions inside the host. They provide resistance against temperature changes, acidic pH, oxidative stress, antimicrobial peptides and lysosomal enzymes. Heat-shock proteins, superoxide dismutase and protective cell-wall components are included in this type.

How Virulence Factors Help Pathogens Cause Disease

Virulence factors are the properties, structures and products which help a pathogen to establish infection and cause disease. These factors are used during different stages of pathogenesis. Entry into host, attachment, colonisation, invasion, survival, immune evasion and tissue damage.

1. Attachment to Host Cells

• Attachment is the first important step during pathogenesis. It prevents the pathogen from being removed by mucus, urine and other body fluids.
• Adhesins are surface molecules which bind with specific receptors present on host cells. These may be present on bacterial pili, fimbriae, flagella, viral capsid or envelope.
• The binding of adhesin with host receptor determines the tissue preference of pathogen. This is referred to as tropism.
• Type 1 fimbriae of Escherichia coli help in attachment with epithelial cells. Influenza virus uses hemagglutinin, while HIV uses the glycoprotein gp120 for attachment with CD4 receptor.

2. Colonisation of Host Tissues

• After attachment, the pathogen starts multiplication at the portal of entry. A microbial population is now established on host tissue.
• Some bacteria form biofilms for firm colonisation. Biofilm is a group of microorganisms enclosed within an extracellular polymeric substance (EPS).
• The EPS forms a thick and sticky covering around microbial cells. It helps in attachment with host tissue and medical devices.
• Biofilm also reduces penetration of antibiotics and protects the organisms from antibodies, complement proteins and phagocytic cells.

3. Invasion and Spread

• Some pathogens remain on epithelial surfaces, while others enter deeper tissues. Different enzymes and invasion proteins are used during this process.
• Hyaluronidase breaks hyaluronic acid present between connective tissue cells. Collagenase degrades collagen and allows the pathogen to spread through tissue layers.
• DNase breaks extracellular DNA and neutrophil extracellular traps which may trap bacterial cells. Kinases dissolve fibrin clots and clear the path for spread.
• Some pathogens produce invasins which bind with host-cell receptors. Other pathogens cause membrane ruffling and force the host cell to take them inside.

4. Survival Inside the Host

• The internal environment of host is not always suitable for microbial growth. Pathogens face acidic pH, temperature changes, low oxygen and oxidative stress.
• Some intracellular pathogens survive even after their engulfment by phagocytic cells. Listeria monocytogenes produces phospholipases which break the phagosome membrane and allow escape into cytoplasm.
• Mycobacterium tuberculosis possesses a waxy mycolic acid layer. It resists lysosomal enzymes and also prevents fusion of phagosome with lysosome.
• During unfavourable conditions, some pathogens reduce their metabolic activity and enter a dormant state. This helps in long-term survival inside the host.

5. Evasion of Host Immunity

• Immune-evasion factors protect the pathogen from antibodies, complement proteins and phagocytic cells.
• A thick polysaccharide capsule covers the surface antigens. It prevents recognition, attachment and engulfment by phagocytes.
• Some pathogens produce proteases which degrade host antibodies. Coagulase produces a fibrin covering around bacterial cells and provides protection from immune cells.
• Antigenic variation is the change of surface antigens by the pathogen. Due to this change, the antibodies formed earlier cannot recognize the organism properly.
• Influenza viruses show antigenic drift and antigenic shift. Neisseria gonorrhoeae also changes its pili during infection.
• Some viruses form membrane structures inside host cells. These structures hide viral nucleic acid from immune receptors and delay antiviral response.

6. Host-Tissue Damage

• Tissue damage is produced by toxins, enzymes and inflammatory reactions. The severity depends on the type and quantity of virulence factors produced.
• Endotoxin is the lipid A component of lipopolysaccharide (LPS) present in Gram-negative bacteria. It is released mainly after bacterial cell damage and causes fever, inflammation, low blood pressure and septic shock.
• Exotoxins are toxic proteins secreted by bacterial cells. They act on specific host cells and cellular activities.
• A-B toxins contain a binding part and an active part. The binding part attaches with host cell, while the active part enters the cell and affects its internal process.
• Membrane-disrupting toxins form pores or degrade membrane phospholipids. The host cell loses its contents and undergoes lysis.
• Superantigens cause non-specific activation of a large number of T cells. During this process, excess cytokines are released and a cytokine storm may develop.
• Sometimes tissue damage is also caused by excessive host inflammatory response. Not only by direct microbial action.

7. Nutrient Acquisition

• Pathogens require iron and other nutrients for their growth inside the host. But free iron is present in very low amount.
• Most of the host iron is bound with haemoglobin, transferrin and lactoferrin. Pathogens produce siderophores to obtain this iron.
• Siderophores bind strongly with iron and remove it from host proteins. The iron-siderophore complex is then transported into the microbial cell.
• Some pathogens also possess special receptors and secretion systems for acquisition of haem and other nutrients. These nutrients support microbial multiplication and continuation of infection.

Common Bacterial Virulence Factors

The following are the common virulence factors present in bacterial pathogens-

• Adhesion factors (Adhesins)– These are surface structures which help the bacterial cells to attach with specific host-cell receptors. Fimbriae, Type 1 pili, Type IV pili and other surface proteins are included in this type. It also prevents removal of bacteria by mucus and body fluids.
• Capsules– Capsule is a thick protective layer present outside the bacterial cell. It is generally made up of polysaccharides. The capsule covers the surface antigens and prevents recognition and phagocytosis by host immune cells.
• Exoenzymes– These are extracellular enzymes secreted by bacterial cells. Hyaluronidase, collagenase, coagulase and DNase are some important exoenzymes. They break connective tissues, extracellular matrix and other host barriers, which helps in invasion and spread.
• Exotoxins– Exotoxins are highly toxic protein substances secreted by living bacterial cells. Most of them are heat-labile. They include A-B toxins, membrane-disrupting toxins and superantigens. Different cellular functions are affected by them.
• Endotoxins– Endotoxin is the lipid A component of lipopolysaccharide (LPS) present in outer membrane of Gram-negative bacteria. It is heat-stable and commonly released after lysis of bacterial cells. Fever, severe inflammation, low blood pressure and septic shock may occur.
• Siderophores– These are iron-binding molecules produced by bacteria. They bind iron with high affinity and remove it from host proteins such as haemoglobin and transferrin. The obtained iron is used for bacterial growth and multiplication.
• Secretion systems– These are complex protein structures present across the bacterial cell membrane. Different systems such as Type I to Type IX secretion systems transport toxins, enzymes and virulence effector proteins. Some of them inject these proteins directly into the host cell.
• Outer membrane vesicles (OMVs)– These are small spherical membrane vesicles released by Gram-negative bacteria. They carry toxins, enzymes, proteins and DNA. OMVs may also bind with antimicrobial agents and prevent them from reaching the bacterial cell.
• Biofilms– Biofilm is a structured community of bacterial cells enclosed within a self-produced polymeric matrix. It helps the bacteria to attach with tissues and medical devices. The matrix also protects them from immune cells and reduces the action of antimicrobial drugs.
• Specific immune-evasion factors– These are bacterial structures or proteins which prevent destruction by the host immune system. The waxy mycolic acid layer of Mycobacterium tuberculosis resists lysosomal digestion. M protein of Streptococcus prevents complement binding and reduces phagocytosis.

Common Viral Virulence Factors

The following are the common virulence factors present in viral pathogens-

• Adhesion factors (Viral adhesins)– These are proteins or glycoproteins present on viral capsid or envelope. They bind with specific receptors of host cells and determine the tissue or host infected by virus. Spike (S) protein of SARS-CoV-2, hemagglutinin of Influenza virus and gp120 of HIV are some examples.
• Antigenic variation– It is the continuous change of viral surface antigens. Due to this change, antibodies formed earlier cannot recognize the virus properly. Antigenic drift occurs by small mutations, while antigenic shift occurs by major mixing or reassortment of viral genes.
• Release enzymes– These enzymes help the newly formed viral particles to separate from host cell and infect other cells. Neuraminidase of Influenza virus breaks sialic acid present on host-cell surface. The progeny virions are then released.
• Replication organelles or double-membrane vesicles– Some RNA viruses change the host intracellular membranes and form double-membrane vesicles (DMVs). Viral replication takes place inside these vesicles. It also hides viral genetic material from immune sensors of host cell.
• RNA modification and cap snatching– Some viruses modify the 5′ end of their RNA and make it similar to host mRNA. Coronaviruses use methyltransferase enzymes for capping of viral RNA. Influenza virus removes 5′ caps from host RNA and uses them during viral replication. This is referred to as cap snatching.
• Interferon antagonists– These are viral proteins which prevent production or action of antiviral interferons. NS1 protein of Influenza virus, NS5 of Zika virus, Nef of HIV and ORF6 of SARS-CoV-2 are included in this type. They reduce the innate immune response of host.
• Host translation and trafficking inhibitors– These viral proteins affect the normal protein synthesis and mRNA processing of host cell. The host machinery is then used mainly for production of viral proteins. Formation of defensive host proteins is also reduced.

Common Fungal Virulence Factors

The following are the common virulence factors present in fungal pathogens-

• Adhesion factors (Adhesins)– These are surface glycoproteins which help fungal cells to attach with host tissues, epithelial cells and medical devices. The Als proteins and Hwp1 of Candida and RodA of Aspergillus are some examples. Firm attachment. It is required for colonisation and further infection.
• Dimorphism or morphological plasticity– Some fungal pathogens can change from one morphological form to another. Yeast form may change into filamentous hyphae during infection. The hyphae penetrate mucosal surfaces and enter deeper tissues. Candida, Histoplasma and Blastomyces show this property.
• Thermal adaptation (Thermotolerance)– Pathogenic fungi can survive at mammalian body temperature. Heat-shock proteins such as HSP70 and HSP90 maintain the stability of fungal proteins during high temperature and fever. This helps in growth and survival inside the host.
• Secreted enzymes– Fungal pathogens secrete different hydrolytic enzymes. Secreted aspartyl proteases (SAPs) break host proteins, cell barriers, complement proteins and antimicrobial peptides. These enzymes help in tissue invasion and immune evasion.
• Toxins– Some fungi produce toxic substances which damage host cells. Candida albicans produces candidalysin, which forms pores in host-cell membrane and causes cell lysis. Aspergillus produces gliotoxin. It suppresses immune activity and may cause death of immune cells.
• Cell-wall remodelling and shielding– Fungal pathogens change their cell-wall composition during infection. Cryptococcus produces a thick polysaccharide capsule, while other fungi increase chitin formation and make the wall more resistant. Melanin also covers surface antigens and neutralises reactive oxygen species produced by immune cells.
• Biofilm formation– Fungal cells may grow as an organised community enclosed within a polymeric matrix. Biofilm helps in firm attachment with host tissues and medical catheters. It also prevents proper penetration of antifungal drugs. Persistent infection is commonly produced.
• Nutrient acquisition (Siderophores)– Fungi require iron and other nutrients for their growth. Siderophores bind iron from host proteins and transport it into fungal cells. Aspergillus uses siderophore-related factors such as SidA for iron acquisition, survival and tissue invasion.

Regulation of Virulence Factors

Pathogens do not produce all virulence factors continuously. Their expression is increased or decreased depending on host condition and stage of infection. This saves cellular energy, helps in adaptation and also prevents early recognition by the host immune system.

The following are the major mechanisms involved in regulation of virulence factors-

1. Sensing of Environmental Conditions

Pathogens detect different physical and chemical conditions present inside the host. These signals activate or inhibit the virulence genes.

• Temperature– Mammalian body temperature around 37°C acts as an important signal for many pathogens. In Candida albicans, it activates the genes involved in conversion of yeast cells into tissue-invading hyphae. Aspergillus fumigatus also increases cell-wall synthesis at this temperature.
• pH level– Acidic or alkaline condition affects the expression of virulence factors. Acidic environment inside macrophage phagosome activates the PhoPR system of Mycobacterium tuberculosis. In Candida albicans, the Hda1 enzyme controls morphological change according to pH.
• Oxygen and nutrient level– Low oxygen and nutrient deficiency activate different survival pathways. In hypoxic lung granuloma, M. tuberculosis activates the dosR regulon and enters into a dormant state. Low iron and oxygen also activate the SidA gene in A. fumigatus for iron acquisition.
• Microbiota metabolites– Chemicals formed by normal microbiota can affect pathogen behaviour. High concentration of short-chain fatty acids (SCFAs) in colon decreases adhesion and motility genes of Escherichia coli. In ileum, lower concentration may increase the expression of same factors.

2. Quorum Sensing

Quorum sensing is a bacterial communication process based on the production and detection of chemical molecules called autoinducers. It allows the bacteria to detect their population density.

• When bacterial population is low, the genes required for attachment and colonisation are generally activated.
• After reaching a critical population density, toxin and tissue-degrading enzyme genes are activated. A coordinated response.
• The agr locus of Staphylococcus aureus is an important example. At low cell density, adhesion factors are produced. At high cell density, adhesion genes are reduced and toxin production is increased.

3. Response to Host Immune Pressure

Host immune attack also changes the expression of virulence factors. During this process, pathogens activate protective and survival-related genes.

• Oxidative-stress response– Phagocytic cells produce reactive oxygen species (ROS) for destruction of pathogens. In S. aureus, oxidative stress can activate the icaABCD genes and increase biofilm formation. In Candida auris, ROS activates the HSP90-calcineurin pathway, which helps in fungal survival.
• CRISPR-Cas regulation– Some bacteria use the CRISPR-Cas system for regulation of their own virulence genes. Under strong immune pressure, Salmonella enterica may use Cas12a to cleave virulence RNA transcripts. The acute virulence is reduced and a persistent infection may be formed.

4. Epigenetic and Chromatin Remodelling

Pathogens can regulate gene expression without changing the DNA sequence. This is carried out by changing the arrangement of chromatin and histone proteins.

• Fungal pathogens commonly use histone-modifying enzymes for this process.
• Histone acetyltransferases, such as Gcn5, increase acetylation of histones. Histone deacetylases remove these groups.
• These changes control large groups of virulence genes involved in adhesion, cell-wall formation, morphological change and tissue invasion.

5. Co-regulation with Antimicrobial Resistance

Virulence genes and antimicrobial-resistance genes may be present on the same plasmid, transposon or other mobile genetic element. Sometimes they also remain under a common regulatory system.

• Due to this association, exposure to antimicrobial drugs may affect the expression of virulence factors.
• In Enterococcus faecalis, vancomycin stress activates the RpoS regulatory factor.
• During this process, the vanA gene responsible for vancomycin resistance and the gelE gene responsible for tissue-degrading enzyme production may be activated together.
• Thus, antimicrobial pressure may increase resistance and virulence at the same time in some pathogens.

Examples of Pathogens and Their Virulence Factors

Bacterial Pathogens

Viral Pathogens

Fungal Pathogens

Host Factors Affecting Pathogen Virulence

The severity of infection not only depends on virulence factors of pathogen. Different conditions of host also affect the multiplication, spread and tissue damage produced by microorganisms. The following are the major host factors affecting pathogen virulence-

1. Age– Infants and elderly people are more susceptible to infection. In infants, the immune system is not fully developed, while in elderly people both innate and adaptive immune responses become weak. Severe disease is therefore more common in these age groups.
2. Immune system status– The immune condition of host is an important factor which determines severity of disease. Immunosuppression caused by HIV/AIDS, chemotherapy, immunosuppressive drugs or genetic defects allows rapid multiplication of pathogens. On the other hand, excessive immune response may also damage normal tissues. Cytokine storm and toxic shock are some examples.
3. Resident microbiota– Normal microbiota present on skin and mucosal surfaces prevent the growth of pathogens. They compete for nutrients, space and attachment sites. During antibiotic treatment, this microbiota may be disturbed. Opportunistic pathogens can now multiply and cause infection.
4. Integrity of physical barriers– Intact skin and mucosal surfaces form the first line of defence. Mucus, antimicrobial secretions and continuous replacement of epithelial cells also prevent pathogen entry. Burns, wounds, surgery, catheterisation and tracheal intubation break these barriers and provide direct portal of entry.
5. Underlying diseases– Pre-existing diseases can decrease natural resistance of host. In cystic fibrosis, thick mucus and poor ciliary movement reduce microbial clearance from lungs. Urinary obstruction supports bacterial growth in urinary tract. In diabetes, increased glucose level may support fungal and bacterial multiplication.
6. Hormonal fluctuations– Hormonal changes can alter the local environment of host tissues. Reduced estrogen during menstruation or menopause decreases lactic acid production by vaginal lactobacilli. The vaginal pH now increases, which may support the growth of Candida and other opportunistic organisms.
7. Nutrient sequestration– The host limits microbial growth by keeping essential nutrients unavailable. Free iron is present in very low amount because it remains bound with transferrin, lactoferrin and haemoglobin. Pathogens which cannot obtain this iron show reduced growth, while organisms producing siderophores may continue multiplication.

Methods Used for Measurement of Pathogen Virulence

The following are the important methods used for measurement of pathogen virulence–

• Median Lethal Dose (LD₅₀)– It is the number of pathogen cells, viral particles or amount of toxin required to kill 50% of experimentally infected animals. A pathogen with lower LD₅₀ is considered more virulent. Less dose, greater killing effect.
• Median Infectious Dose (ID₅₀)– It is the number of pathogen cells or virions required to produce infection in 50% of inoculated test animals. A lower ID₅₀ indicates that only a small number of pathogens are required for establishing infection.
• Median Effective Dose (ED₅₀)– It is the dose of a pathogen required to produce a defined symptom, lesion or biological effect in 50% of experimental animals. The effect is generally measured within a fixed period of time.

Clinical Importance of Virulence Factors

The following are some of the important clinical importance of virulence factors–

• Development of anti-virulence drugs– These drugs are used to block the virulence factor without directly killing the pathogen. Toxins, adhesins, secretion systems and biofilm formation can be inhibited. Due to this, less pressure is produced for development of antimicrobial resistance. Normal microbiota is also not greatly affected.
• Vaccine development– Virulence factors can be used as antigens during vaccine preparation. Bacterial capsule, toxins and viral surface proteins are some of them. The Spike (S) protein of SARS-CoV-2 was used as the major target during development of mRNA vaccines.
• Diagnosis of pathogenic strains– Detection of virulence genes helps to separate highly pathogenic strains from less harmful strains. PCR, mass spectrometry and other molecular methods are used for detection. The presence of toxin gene, capsule gene or adhesion gene can now be identified.
• Selection of treatment– The type of virulence factor produced by a pathogen can help in selection of treatment. A toxin-producing strain may need antitoxin or antibody treatment, while a biofilm-producing strain may need drugs which can penetrate the biofilm. Broad treatment is not always required.
• Passive immunotherapy– Monoclonal antibodies can be prepared against toxins, adhesins and other virulence factors. These antibodies bind with the factor and inhibit its activity. Tissue damage can be reduced before it becomes severe.
• Combination treatment– Anti-virulence drugs can be used with antibiotics. Inhibition of biofilm increases entry of antibiotic into microbial cells. Blocking of toxins also decreases host-cell damage. Lower dose of antibiotic may become effective during this process.
• Prediction of disease severity– Some strains possess more virulence factors than others. These strains may cause severe tissue damage, septic shock or multi-organ failure. Detection of these factors helps to identify high-risk infection at an early stage.
• Understanding disease process– Study of virulence factors explains how a pathogen attaches, invades, survives and causes damage inside the host. It also helps to understand why the same microorganism produces mild disease in one patient and severe disease in another.

Reference

1. Access to Medicine Foundation. (2022). Thin pipeline, high stakes: How are companies planning to expand access to vital, new antimicrobials?
2. Advances in the study of bacterial toxins, their roles and mechanisms in pathogenesis. (n.d.). [URL]
3. Ahmed, M. (2024). Pathogenicity and virulence: Concepts in microbial pathogenesis. Longdom Publishing.
4. Aridis Pharmaceuticals. (2021). Aridis Pharmaceuticals announces exclusive license of suvratoxumab, a Phase 3-ready monoclonal antibody, from AstraZeneca. PR Newswire.
5. Assembly of the Mycobacterium tuberculosis type VII ESX-1 secretion system in Mycobacterium smegmatis identifies a new transcriptional activator of esx-1 genes and a novel TB vaccine. (n.d.). Microbiology Spectrum – ASM Journals. [URL]
6. Bacterial endotoxins and exotoxins in intensive care medicine. (n.d.). PMC – NIH. [URL]
7. Bacterial protein secretion systems: Mechanisms, functions, and roles in virulence. (n.d.). PubMed. [URL]
8. Beyer, D. K., & Forero, A. (2022). Mechanisms of antiviral immune evasion of SARS-CoV-2. Journal of Molecular Biology, 434(6), 167265.
9. Candidalysin: Connecting the pore forming mechanism of this virulence factor to its immunostimulatory properties. (n.d.). PMC. [URL]
10. Characterizing the novel pore formation mechanism of the Candida albicans virulence factor candidalysin. (2026). University of Tennessee, Knoxville. [URL]
11. Chen, Y., Wu, X., Xu, C., Huang, J., Zhang, L., Qiu, P., Zheng, D., Chen, W., & Zhang, S. (2025). Pathogen virulence genes: Advances, challenges and future directions in infectious disease research (Review). International Journal of Molecular Medicine, 56(5), 173.
12. ClinicalTrials.Veeva. (n.d.). A human monoclonal antibody against Staphylococcus aureus alpha toxin in mechanically ventilated adult subjects – 2.
13. CuriouSTEM. (n.d.). Pathogenicity and virulence.
14. Depluverez, S., Devos, S., & Devreese, B. (2016). The role of bacterial secretion systems in the virulence of Gram-negative airway pathogens associated with cystic fibrosis. Frontiers in Microbiology, 7, 1336.
15. DYRK-family kinases regulate Candida albicans morphogenesis and virulence through the Ras1/PKA pathway. (n.d.). PMC. [URL]
16. European Biotechnology. (n.d.). Infex reports Phase IIa win for anti-Pseudomonas antibody.
17. Hadi, A. M., & Abd, Z. A. H. (n.d.). Pathogenecity and virulence. Al Mustaqbal University.
18. Hulshizer, R., Lynch, M., De Lurio, J., et al. (2021). Suvratoxumab (AR-320, MEDI4893) to prevent Staphylococcus aureus–acquired pneumonia. PCORI Health Care Horizon Scanning System Database.
19. Ibrahim, A. S., et al. (2018). The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. bioRxiv.
20. Infect and inject: How Mycobacterium tuberculosis exploits its major virulence-associated type VII secretion system, ESX-1. (n.d.). ASM Journals. [URL]
21. Infex Therapeutics. (2026). Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa. GlobeNewswire.
22. Infex Therapeutics. (2026). Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections. GlobeNewswire.
23. Infex Therapeutics. (n.d.). Infex to present RESP-X Phase I data at ERS Congress.
24. Innovative solutions to sticky situations: Antiadhesive strategies for treating bacterial infections. (n.d.). ASM Journals. [URL]
25. Kumar, A., Kothari, A., Kumar, P., Pai, M., Mohan, K., & Omar, B. J. (2023). A review on various secretion systems: A versatile molecular weapon for bacterial pathogenesis, special reference to type 7 secretion system (T7SS) in multi drug resistance Staphylococcus aureus. Annals of Infectious Diseases & Preventive Medicine, 1(1), 1005.
26. Leibniz-HKI. (n.d.). The laborious path of a fungal toxin.
27. Leinco Technologies. (2024). Anti-RSV F protein (Palivizumab) [Clone MEDI493].
28. Li, J.-Y., Zhou, Z.-J., Wang, Q., He, Q.-N., Zhao, M.-Y., Qiu, Y., & Ge, X.-Y. (2021). Innate immunity evasion strategies of highly pathogenic coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2. Frontiers in Microbiology, 12, 770656.
29. Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection. (n.d.). PNAS. [URL]
30. Microbiology Info.com. (n.d.). Differences between exotoxins and endotoxins.
31. Microbiology Society. (2023). Bacterial secretion system functions: Evidence of interactions and downstream implications. Microbiology, 169, 001326.
32. Microbial virulence factors. (n.d.). PMC – NIH. [URL]
33. Nosanchuk, J. D. (2025). mGem: A quarter century with the Pirofski–Casadevall damage response framework—a dynamic construct for understanding microbial pathogenesis. mBio, 16(3), e02945-24.
34. OpenStax. (2012). How pathogens cause disease. Microbiology – Lumen Learning.
35. OpenStax. (2012). Virulence factors of bacterial and viral pathogens. Microbiology – Lumen Learning.
36. Pathogen virulence factors: Molecular mechanisms, host-pathogen dynamics, and next-generation anti-virulence therapeutics. (n.d.). [URL]
37. Pathogenesis is not a trait—It’s an outcome. (n.d.). American Society for Microbiology. [URL]
38. Patient Worthy. (2026). Infex Therapeutics reports positive Phase IIa data for RESP-X in bronchiectasis patients with Pseudomonas colonisation.
39. Patsnap Synapse. (2023). NDV-3 – Drug targets, indications, patents.
40. Patsnap Synapse. (2023). What is the mechanism of Palivizumab?.
41. Peterson, J. W. (1996). Bacterial pathogenesis. In S. Baron (Ed.), Medical Microbiology (4th ed., Chapter 7). University of Texas Medical Branch at Galveston.
42. Pharmacology of Palivizumab (Synagis); Mechanism of action, pharmacokinetics, uses, effects. (n.d.). Youtube. [URL]
43. Pirofski, L. A., & Casadevall, A. (2008). The damage-response framework of microbial pathogenesis and infectious diseases. In G. Huffnagle & M. Noverr (Eds.), GI Microbiota and Regulation of the Immune System (pp. 135-146). Advances in Experimental Medicine and Biology, Vol. 635.
44. Pruksaphon, K., Amsri, A., Jeenkeawpieam, J., Thammasit, P., Nosanchuk, J. D., & Youngchim, S. (2024). The microbial damage and host response framework: lesson learned from pathogenic survival trajectories and immunoinflammatory responses of Talaromyces marneffei infection. Frontiers in Immunology, 15, 1448729.
45. Psonis, J. J., & Thanassi, D. G. (2019). Therapeutic approaches targeting the assembly and function of chaperone-usher pili. EcoSal Plus, 8(2).
46. Rashid, F., Xie, Z., Suleman, M., Shah, A., Khan, S., & Luo, L. (2022). Roles and functions of SARS-CoV-2 proteins in host immune evasion. Frontiers in Immunology, 13, 940756.
47. Regulation of hyphal development by protein kinase A, stress-responsive MAP kinases, and calcineurin via transcription factors Sfl1 and Sfl2 in Candida albicans. (n.d.). mSphere – ASM Journals. [URL]
48. Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion. (n.d.). PMC. [URL]
49. Russell, C. M., Schaefer, K. G., Dixson, A., Gray, A. L. H., Pyron, R. J., Alves, D. S., Moore, N., Conley, E. A., Schuck, R. J., White, T. A., Do, T. D., King, G. M., & Barrera, F. N. (2022). The Candida albicans virulence factor candidalysin polymerizes in solution to form membrane pores and damage epithelial cells. eLife, 11, e75490.
50. SARS-CoV-2 evasion of the interferon system: Can we restore its effectiveness? (n.d.). PMC. [URL]
51. Shaner, G., Stromberg, E. L., Lacy, G. H., Barker, K. R., & Pirone, T. P. (1992). Nomenclature and concepts of pathogenicity and virulence. Annual Review of Phytopathology, 30, 47-66.
52. Shehan, M. A., & Hajwal, S. I. (2026). Microbial toxins: Types, mechanisms of action, and pathogenic significance. Indonesian Journal on Health Science and Medicine, 3(1).
53. Shivarathri, R., Tscherner, M., Zwolanek, F., Singh, N. K., Chauhan, N., & Kuchler, K. (2019). The fungal histone acetyl transferase Gcn5 controls virulence of the human pathogen Candida albicans through multiple pathways. Scientific Reports, 9, 9445.
54. Small molecules that sabotage bacterial virulence. (n.d.). PMC – NIH. [URL]
55. Study.com. (n.d.). Flu viruses, HIV and immune system evasion.
56. Sundaram, K., Rathinam, S., Bethunaickan, R., Ranganathan, U. D., Prabhu, V., & Dhanapal, M. (2026). Functional analysis of type VII secretion system links to host immune evasion mechanism in Mycobacterium tuberculosis. Frontiers in Cellular and Infection Microbiology, 16, 1797994.
57. Targeting the bacteria–host interface: Strategies in anti-adhesion therapy. (n.d.). PMC – NIH. [URL]
58. Tay, D. J. W., Lew, Z. Z. R., Chu, J. J. H., & Tan, K. S. (2022). Uncovering novel viral innate immune evasion strategies: What has SARS-CoV-2 taught us?. Frontiers in Microbiology, 13, 844447.
59. The Antibody Society. (n.d.). Suvratoxumab No development reported Naked monospecific.
60. The dual function of the fungal toxin candidalysin during Candida albicans—Macrophage interaction and virulence. (n.d.). PMC. [URL]
61. The Type IX secretion system and its role in bacterial function and pathogenesis. (n.d.). [URL]
62. The damage-response framework of microbial pathogenesis. (n.d.). PMC – NIH. [URL]
63. Tortora 14th Edition. (n.d.). Compare pathogenicity with virulence. Pearson.
64. Uppuluri, P., Singh, S., Alqarihi, A., Schmidt, C. S., Hennessey, J. P., Jr, Yeaman, M. R., Filler, S. G., Edwards, J. E., & Ibrahim, A. S. (2018). Human anti-Als3p antibodies are surrogate markers of NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis. Frontiers in Immunology, 9, 1349.
65. VFDB. (2026). VFDB: Virulence factors of bacterial pathogens.
66. Virulence regulation and drug-resistance mechanism of fungal infection. (n.d.). PMC. [URL]
67. Wang, H., Sun, J., Ma, G., You, F., Heng, B. C., Bai, Y., & Deng, X. (2025). The role and mechanism of bacterial outer membrane vesicles in the development of periodontitis. Frontiers in Microbiology, 16, 1654137.
68. Wikipedia. (2025). Molecular Koch’s postulates.
69. Wikipedia. (2025). Palivizumab.
70. Wikipedia. (2026). Type VII secretion system.
71. World Health Organization. (2024). Antifungal agents in development.